Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Bowen

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
Annals of the New York Academy of Sciences|November 1, 2003
Antibodies in myasthenia gravis and related disordersAngela Vincent, John McConville, Maria Elena Farrugia, et al.
Biorxiv : the Preprint Server for Biology|January 5, 2021
Structural basis for broad coronavirus neutralizationMaximilian M Sauer, M Alexandra Tortorici, Young-Jun Park, et al.
Biorxiv : the Preprint Server for Biology|October 21, 2021
Antibody-mediated broad sarbecovirus neutralization through ACE2 molecular mimicryYoung-Jun Park, Anna De Marco, Tyler N Starr, et al.
Medrxiv : the Preprint Server for Health Sciences|February 23, 2021
SARS-CoV-2 B.1.1.7 sensitivity to mRNA vaccine-elicited, convalescent and monoclonal antibodiesDami A Collier, Anna De Marco, Isabella A T M Ferreira, et al.
Biorxiv : the Preprint Server for Biology|March 24, 2021
Elicitation of broadly protective sarbecovirus immunity by receptor-binding domain nanoparticle vaccinesAlexandra C Walls, Marcos C Miranda, Minh N Pham, et al.
Nature|March 11, 2021
Sensitivity of SARS-CoV-2 B.1.1.7 to mRNA vaccine-elicited antibodiesDami A Collier, Anna De Marco, Isabella A T M Ferreira, et al.
Science (New York, N.Y.)|September 25, 2020
Ultrapotent human antibodies protect against SARS-CoV-2 challenge via multiple mechanismsM Alejandra Tortorici, Martina Beltramello, Florian A Lempp, et al.
Cell|October 7, 2021
Elicitation of broadly protective sarbecovirus immunity by receptor-binding domain nanoparticle vaccinesAlexandra C Walls, Marcos C Miranda, Alexandra Schäfer, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Annals of the New York Academy of Sciences|November 1, 2003
Antibodies in myasthenia gravis and related disordersAngela Vincent, John McConville, Maria Elena Farrugia, et al.
Biorxiv : the Preprint Server for Biology|January 5, 2021
Structural basis for broad coronavirus neutralizationMaximilian M Sauer, M Alexandra Tortorici, Young-Jun Park, et al.
Biorxiv : the Preprint Server for Biology|October 21, 2021
Antibody-mediated broad sarbecovirus neutralization through ACE2 molecular mimicryYoung-Jun Park, Anna De Marco, Tyler N Starr, et al.
Medrxiv : the Preprint Server for Health Sciences|February 23, 2021
SARS-CoV-2 B.1.1.7 sensitivity to mRNA vaccine-elicited, convalescent and monoclonal antibodiesDami A Collier, Anna De Marco, Isabella A T M Ferreira, et al.
Biorxiv : the Preprint Server for Biology|March 24, 2021
Elicitation of broadly protective sarbecovirus immunity by receptor-binding domain nanoparticle vaccinesAlexandra C Walls, Marcos C Miranda, Minh N Pham, et al.
Nature|March 11, 2021
Sensitivity of SARS-CoV-2 B.1.1.7 to mRNA vaccine-elicited antibodiesDami A Collier, Anna De Marco, Isabella A T M Ferreira, et al.
Science (New York, N.Y.)|September 25, 2020
Ultrapotent human antibodies protect against SARS-CoV-2 challenge via multiple mechanismsM Alejandra Tortorici, Martina Beltramello, Florian A Lempp, et al.
Cell|October 7, 2021
Elicitation of broadly protective sarbecovirus immunity by receptor-binding domain nanoparticle vaccinesAlexandra C Walls, Marcos C Miranda, Alexandra Schäfer, et al.
Pageof 3